Moderna Inc (MRNA)
37.58
+0.64
(+1.73%)
USD |
NASDAQ |
Nov 21, 14:07
Moderna Price to Book Value: 1.212 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.192 |
| November 19, 2024 | 1.203 |
| November 18, 2024 | 1.275 |
| November 15, 2024 | 1.189 |
| November 14, 2024 | 1.283 |
| November 13, 2024 | 1.360 |
| November 12, 2024 | 1.402 |
| November 11, 2024 | 1.379 |
| November 08, 2024 | 1.511 |
| November 07, 2024 | 1.622 |
| November 06, 2024 | 1.672 |
| November 05, 2024 | 1.719 |
| November 04, 2024 | 1.727 |
| November 01, 2024 | 1.763 |
| October 31, 2024 | 1.754 |
| October 30, 2024 | 1.766 |
| October 29, 2024 | 1.782 |
| October 28, 2024 | 1.769 |
| October 25, 2024 | 1.714 |
| October 24, 2024 | 1.704 |
| October 23, 2024 | 1.723 |
| October 22, 2024 | 1.724 |
| October 21, 2024 | 1.737 |
| October 18, 2024 | 1.746 |
| October 17, 2024 | 1.770 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.855 |
| October 15, 2024 | 1.85 |
| October 14, 2024 | 1.864 |
| October 11, 2024 | 1.882 |
| October 10, 2024 | 1.834 |
| October 09, 2024 | 1.90 |
| October 08, 2024 | 1.885 |
| October 07, 2024 | 1.896 |
| October 04, 2024 | 1.943 |
| October 03, 2024 | 1.971 |
| October 02, 2024 | 2.039 |
| October 01, 2024 | 2.064 |
| September 30, 2024 | 2.157 |
| September 27, 2024 | 2.158 |
| September 26, 2024 | 2.098 |
| September 25, 2024 | 2.089 |
| September 24, 2024 | 2.099 |
| September 23, 2024 | 2.105 |
| September 20, 2024 | 2.156 |
| September 19, 2024 | 2.232 |
| September 18, 2024 | 2.293 |
| September 17, 2024 | 2.363 |
| September 16, 2024 | 2.270 |
| September 13, 2024 | 2.241 |
| September 12, 2024 | 2.287 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.189
Minimum
Nov 15 2024
29.17
Maximum
Aug 09 2021
7.822
Average
4.010
Median
Jul 29 2024
Price to Book Value Benchmarks
| Eli Lilly and Co | 50.02 |
| Merck & Co Inc | 5.635 |
| Pfizer Inc | 1.537 |
| Novavax Inc | -- |
| Vertex Pharmaceuticals Inc | 7.425 |
Price to Book Value Related Metrics
| PS Ratio | 2.875 |
| Price | 37.58 |
| Earnings Yield | -15.49% |
| Market Cap | 14.46B |